Press releases

Month Year

Email alerts

Apr 9, 2014

Medtronic Announces CE Mark and European Launch of First Implantable Cardioverter-Defibrillator System to Allow for Full-Body MRI Scans

Evera MRI(TM) ICD System Is First to Combine Proven Treatment Performance, Increased Longevity, Improved Comfort with Full-Body MRI Access

MINNEAPOLIS - April 9, 2014 - Medtronic today announced CE (Conformité Européenne) Mark and European launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System,...
Apr 7, 2014

Medtronic Acquires Majority of the Shares of Biostar Creating a New Medtronic-Medicall Collaboration in Turkey

ISTANBUL - April 7, 2014 - Medtronic, Inc. today announced that one of its subsidiaries has acquired a majority of the shares of Biostar, which will assume the distribution of Medtronic products...
Apr 5, 2014

'IN.PACT Admiral' Drug-Coated Balloon From Medtronic Outperforms Standard Angioplasty In Landmark Study

Interventional Treatment of Lower-Extremity Peripheral Arterial Disease With Novel Medical Device Shows Positive Results in IN.PACT SFA Trial

LONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated...
Mar 31, 2014

Medtronic CoreValve® System Demonstrates Long-Term Durability

Final Follow-up of CoreValve CE Pivotal Study Shows Sustained Valve Function

MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...
Mar 30, 2014

Medtronic Wins European Patent Office Ruling

MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent...

Show per page